XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended 100 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Cash flows from operating activities:        
Net loss $ (63,778) $ (32,670) $ (7,649) $ (187,592)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 268 188 330 1,916
Stock-based compensation 2,759 3,637 2,181 15,301
Change in fair value of warrants (7,583) 8,889 (4,461) (4,721)
Loss on disposal of fixed assets       9
Common stock issued in exchange for in-process research and development 17,457     17,457
(Increase) decrease in:        
Collaboration receivable (79)     (79)
Prepaid expenses and other current assets (889) (70) (27) (1,313)
Other noncurrent assets (407) (122) 49 (771)
Deposits (4) (41) 41 (91)
Increase (decrease) in:        
Accounts payable 696 (758) (850) 1,727
Accrued expenses 8,283 1,277 (1,876) 10,821
Deferred revenue 4,333     4,333
Deferred rent 109 (24) (32) 195
Net cash used in operating activities (38,835) (19,694) (12,294) (142,808)
Cash flows from investing activities:        
Purchases of property and equipment (1,156) (186) (11) (3,067)
Proceeds from sale of property and equipment       1
Net cash used in investing activities (1,156) (186) (11) (3,066)
Cash flows from financing activities:        
Stockholders' capital contribution       500
Proceeds from exercise of stock options 980 225 73 1,343
Payments to employees for repurchase of restricted common stock (274) (1,668) (380) (2,321)
Proceeds from exercise of warrants 12,399 72 279 12,749
Proceeds from issuance of common stock and warrants, net 71,207 32,804 49,793 221,556
Proceeds from issuance of preferred stock, net       16,760
Net cash provided by financing activities 84,312 31,433 49,765 250,587
Net increase (decrease) in cash and cash equivalents 44,321 11,553 37,460 104,713
Cash and cash equivalents, beginning of period 60,392 48,839 11,379  
Cash and cash equivalents, end of period 104,713 60,392 48,839 104,713
Supplementary disclosure of cash flow information:        
Cash paid for interest            
Cash paid for income taxes            
Supplementary disclosure of noncash investing and financing activities:        
Warrants issued to placement agents and investors     27,068 47,276
Exercise of liability-classified warrants to common shares 303 49   352
Convertible Preferred Stock
       
Supplementary disclosure of noncash investing and financing activities:        
Preferred stock conversion/exercise of equity-classified warrants to common stock       16,760
Warrant
       
Supplementary disclosure of noncash investing and financing activities:        
Preferred stock conversion/exercise of equity-classified warrants to common stock $ 9,067 $ 239   $ 9,324